Metformin in the management of antipsychotic-induced weight gain - why the 'weight'?

IF 3.2 3区医学 Q2 PSYCHIATRY

Frontiers in Psychiatry Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI:10.3389/fpsyt.2024.1491417

Ita Fitzgerald, Laura J Sahm, Ciara Ní Dhubhlaing, Sarah O'Dwyer, Jean O'Connell, Jennifer Torrens, Erin K Crowley

引用次数: 0

查看原文本刊更多论文

二甲双胍用于治疗抗精神病药物引起的体重增加--为什么是 "体重"？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers in Psychiatry Medicine-Psychiatry and Mental Health

CiteScore

6.20

自引率

8.50%

发文量

2813

审稿时长

14 weeks

期刊介绍： Frontiers in Psychiatry publishes rigorously peer-reviewed research across a wide spectrum of translational, basic and clinical research. Field Chief Editor Stefan Borgwardt at the University of Basel is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. The journal''s mission is to use translational approaches to improve therapeutic options for mental illness and consequently to improve patient treatment outcomes.